Cargando…
Global prevalence of Ascaris infection in humans (2010–2021): a systematic review and meta-analysis
BACKGROUND: Ascariasis is one of the most important neglected tropical diseases of humans worldwide. The epidemiology of Ascaris infection appears to have changed with improvements in sanitation and mass drug administration, but there is no recent information on prevalence worldwide. Here, we perfor...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673379/ https://www.ncbi.nlm.nih.gov/pubmed/36401308 http://dx.doi.org/10.1186/s40249-022-01038-z |
_version_ | 1784832930605957120 |
---|---|
author | Holland, Celia Sepidarkish, Mahdi Deslyper, Gwendoline Abdollahi, Ali Valizadeh, Soghra Mollalo, Abolfazl Mahjour, Sanaz Ghodsian, Sahar Ardekani, Ali Behniafar, Hamed Gasser, Robin B. Rostami, Ali |
author_facet | Holland, Celia Sepidarkish, Mahdi Deslyper, Gwendoline Abdollahi, Ali Valizadeh, Soghra Mollalo, Abolfazl Mahjour, Sanaz Ghodsian, Sahar Ardekani, Ali Behniafar, Hamed Gasser, Robin B. Rostami, Ali |
author_sort | Holland, Celia |
collection | PubMed |
description | BACKGROUND: Ascariasis is one of the most important neglected tropical diseases of humans worldwide. The epidemiology of Ascaris infection appears to have changed with improvements in sanitation and mass drug administration, but there is no recent information on prevalence worldwide. Here, we performed a systematic review and meta-analysis to assess the global prevalence of human Ascaris infection from 2010 to 2021. METHODS: We searched MEDLINE/PubMed, and Scopus databases for studies measuring prevalence of Ascaris infection, published between 1 January 2010 and 1 January 2022. We included studies of the general human population in endemic regions, which used accepted coprodiagnostic methods, and excluded studies of people with occupations with an increased risk or probability of ascariasis and/or specific diseases other than ascariasis. We applied random-effects models to obtain pooled prevalence estimates for six sustainable development goal regions of the world. We extrapolated the prevalence estimates to the global population in 2020, to estimate the number of individuals with Ascaris infection. We conducted multiple subgroup and meta-regression analyses to explore possible sources of heterogeneity, and to assess relationships between prevalence estimates and demographic, socio-economic, geo-climatic factors. RESULTS: Of 11,245 studies screened, we analysed 758 prevalence estimates for a total number of 4,923,876 participants in 616 studies from 81 countries. The global prevalence estimated was 11.01% (95% confidence interval: 10.27–11.78%), with regional prevalences ranging from 28.77% (7.07–57.66%) in Melanesia (Oceania) to 1.39% (1.07–1.74%) in Eastern Asia. We estimated that ~ 732 (682–782) million people harboured Ascaris worldwide in 2021. The infected people in Latin America and the Caribbean region had a higher prevalence of high intensity infection (8.4%, 3.9–14.1%). Prevalence estimates were higher in children, and people in rural communities or in countries or regions with lower income and human development indices. There was a trend for a higher prevalence in regions with increasing mean annual relative humidity, precipitation and environmental temperature. CONCLUSIONS: Our findings indicate that, despite a renewed commitment by some communities or authorities to control ascariasis, a substantial portion of the world’s human population (> 0.7 billion) is infected with Ascaris. Despite the clinical and socioeconomic importance of ascariasis, many past routine surveys did not assess the intensity of Ascaris infection in people. We propose that the present findings might stimulate the development of customised strategies for the improved control and prevention of Ascaris infection worldwide. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-022-01038-z. |
format | Online Article Text |
id | pubmed-9673379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96733792022-11-19 Global prevalence of Ascaris infection in humans (2010–2021): a systematic review and meta-analysis Holland, Celia Sepidarkish, Mahdi Deslyper, Gwendoline Abdollahi, Ali Valizadeh, Soghra Mollalo, Abolfazl Mahjour, Sanaz Ghodsian, Sahar Ardekani, Ali Behniafar, Hamed Gasser, Robin B. Rostami, Ali Infect Dis Poverty Scoping Review BACKGROUND: Ascariasis is one of the most important neglected tropical diseases of humans worldwide. The epidemiology of Ascaris infection appears to have changed with improvements in sanitation and mass drug administration, but there is no recent information on prevalence worldwide. Here, we performed a systematic review and meta-analysis to assess the global prevalence of human Ascaris infection from 2010 to 2021. METHODS: We searched MEDLINE/PubMed, and Scopus databases for studies measuring prevalence of Ascaris infection, published between 1 January 2010 and 1 January 2022. We included studies of the general human population in endemic regions, which used accepted coprodiagnostic methods, and excluded studies of people with occupations with an increased risk or probability of ascariasis and/or specific diseases other than ascariasis. We applied random-effects models to obtain pooled prevalence estimates for six sustainable development goal regions of the world. We extrapolated the prevalence estimates to the global population in 2020, to estimate the number of individuals with Ascaris infection. We conducted multiple subgroup and meta-regression analyses to explore possible sources of heterogeneity, and to assess relationships between prevalence estimates and demographic, socio-economic, geo-climatic factors. RESULTS: Of 11,245 studies screened, we analysed 758 prevalence estimates for a total number of 4,923,876 participants in 616 studies from 81 countries. The global prevalence estimated was 11.01% (95% confidence interval: 10.27–11.78%), with regional prevalences ranging from 28.77% (7.07–57.66%) in Melanesia (Oceania) to 1.39% (1.07–1.74%) in Eastern Asia. We estimated that ~ 732 (682–782) million people harboured Ascaris worldwide in 2021. The infected people in Latin America and the Caribbean region had a higher prevalence of high intensity infection (8.4%, 3.9–14.1%). Prevalence estimates were higher in children, and people in rural communities or in countries or regions with lower income and human development indices. There was a trend for a higher prevalence in regions with increasing mean annual relative humidity, precipitation and environmental temperature. CONCLUSIONS: Our findings indicate that, despite a renewed commitment by some communities or authorities to control ascariasis, a substantial portion of the world’s human population (> 0.7 billion) is infected with Ascaris. Despite the clinical and socioeconomic importance of ascariasis, many past routine surveys did not assess the intensity of Ascaris infection in people. We propose that the present findings might stimulate the development of customised strategies for the improved control and prevention of Ascaris infection worldwide. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-022-01038-z. BioMed Central 2022-11-18 /pmc/articles/PMC9673379/ /pubmed/36401308 http://dx.doi.org/10.1186/s40249-022-01038-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Scoping Review Holland, Celia Sepidarkish, Mahdi Deslyper, Gwendoline Abdollahi, Ali Valizadeh, Soghra Mollalo, Abolfazl Mahjour, Sanaz Ghodsian, Sahar Ardekani, Ali Behniafar, Hamed Gasser, Robin B. Rostami, Ali Global prevalence of Ascaris infection in humans (2010–2021): a systematic review and meta-analysis |
title | Global prevalence of Ascaris infection in humans (2010–2021): a systematic review and meta-analysis |
title_full | Global prevalence of Ascaris infection in humans (2010–2021): a systematic review and meta-analysis |
title_fullStr | Global prevalence of Ascaris infection in humans (2010–2021): a systematic review and meta-analysis |
title_full_unstemmed | Global prevalence of Ascaris infection in humans (2010–2021): a systematic review and meta-analysis |
title_short | Global prevalence of Ascaris infection in humans (2010–2021): a systematic review and meta-analysis |
title_sort | global prevalence of ascaris infection in humans (2010–2021): a systematic review and meta-analysis |
topic | Scoping Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673379/ https://www.ncbi.nlm.nih.gov/pubmed/36401308 http://dx.doi.org/10.1186/s40249-022-01038-z |
work_keys_str_mv | AT hollandcelia globalprevalenceofascarisinfectioninhumans20102021asystematicreviewandmetaanalysis AT sepidarkishmahdi globalprevalenceofascarisinfectioninhumans20102021asystematicreviewandmetaanalysis AT deslypergwendoline globalprevalenceofascarisinfectioninhumans20102021asystematicreviewandmetaanalysis AT abdollahiali globalprevalenceofascarisinfectioninhumans20102021asystematicreviewandmetaanalysis AT valizadehsoghra globalprevalenceofascarisinfectioninhumans20102021asystematicreviewandmetaanalysis AT mollaloabolfazl globalprevalenceofascarisinfectioninhumans20102021asystematicreviewandmetaanalysis AT mahjoursanaz globalprevalenceofascarisinfectioninhumans20102021asystematicreviewandmetaanalysis AT ghodsiansahar globalprevalenceofascarisinfectioninhumans20102021asystematicreviewandmetaanalysis AT ardekaniali globalprevalenceofascarisinfectioninhumans20102021asystematicreviewandmetaanalysis AT behniafarhamed globalprevalenceofascarisinfectioninhumans20102021asystematicreviewandmetaanalysis AT gasserrobinb globalprevalenceofascarisinfectioninhumans20102021asystematicreviewandmetaanalysis AT rostamiali globalprevalenceofascarisinfectioninhumans20102021asystematicreviewandmetaanalysis |